INTERLEUKIN 2, INTERFERON, AND LYMPHOTOXIN IN RENAL TRANSPLANT RECIPIENTS1 Pressented at the 6th Annual Meeting of the American Society of Transplant Physicians, May 1987, Chicago, IL
- 1 January 1988
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 45 (1) , 76-80
- https://doi.org/10.1097/00007890-198801000-00018
Abstract
The immunocuppressive action of cyclosporine in transplantation (Tx) is thought to be due to its potent inhibition of lymphokine production by T cell. Several studies have shown a decrease in interleukin 2 (IL–2) adn interferon-Gamma (IFN-G) production of renal Tx recipients on CsA treatment and have suggested that increased in lymphokine production can be correlatede with rejection epidosodes.In this study we measured IL-2, IFN-G, and lymphotoxin (LT) production by mitogen-stmulated peripheral blood lymphocytes in eight renal Tx recipients before and at various times after Tx. IL-2 production was significantly (PPP<0.05) after treatment. We conclude from these studies that the usefulness of lymphokine determinations for the diagnosis of allograft rejection remians unproved.This publication has 3 references indexed in Scilit:
- Acquired Defect in Interleukin-2 Production in Patients with Type I Diabetes MellitusNew England Journal of Medicine, 1986
- Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription.Proceedings of the National Academy of Sciences, 1984
- T Cell Growth Factor: Parameters of Production and a Quantitative Microassay for ActivityThe Journal of Immunology, 1978